Literature DB >> 8015637

Endothelin in chronic renal failure.

K Takahashi, K Totsune, T Mouri.   

Abstract

Plasma concentrations of IR endothelin are elevated in patients with chronic renal failure. But its exact causes have not been clarified. Hypertension may be one of the most important factors associated with elevated plasma IR endothelin concentrations, although it still remains to be determined whether hypertension is a result or a cause of the elevated plasma IR endothelin concentrations in patients with chronic renal failure. Elevation of plasma IR endothelin concentrations was found in hemodialysis patients with rHuEPO-induced blood pressure elevation. Endothelin may be one of the causes in rHuEPO-induced hypertension in some hemodialysis patients. Endothelin receptors have been cloned, and several endothelin antagonists have been reported. The studies using clinically useful endothelin antagonists will further clarify the pathophysiology of endothelin in patients with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015637     DOI: 10.1159/000187849

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

Review 1.  Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension.

Authors:  J E Donckier
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism.

Authors:  P Lakatos; A Tátrai; J Földes; C Horváth; J Makó; P H Stern
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.